⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27679696 | 0.75 | SLC22A6 (0.45) | — | |
| SCHEMBL6442999 | 0.73 | — | — | |
| SCHEMBL14539493 | 0.73 | — | — | |
| SCHEMBL8169661 | 0.73 | — | — | |
| SCHEMBL2671585 | 0.73 | TET2 (0.50) | — | |
| SCHEMBL584099 | 0.72 | SLC22A6 (0.56) | — | |
| SCHEMBL6022478 | 0.71 | — | — | |
| SCHEMBL11700595 | 0.71 | — | — | |
| SCHEMBL1529128 | 0.71 | — | — | |
| SCHEMBL3328080 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0319927-A2 | Method for preparing multilayered coated articles and the coated articles prepared by the method | PPG INDUSTRIES, INC. (US) | 1989-06-14 | — | — | EP | claimed |
| US-20160175288-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION | 2016-06-23 | — | — | US | disclosed |
| US-20150164772-A1 | Methods and Compositions to Impart Memory Effects onto Biosurfaces | AVON PRODUCTS, INC. | 2015-06-18 | — | — | US | disclosed |
| US-8946144-B2 | Phosphonated glycopeptide and lipoglycopeptide antibiotics and uses thereof for the prevention and treatment of bone and joint infections | THE MEDICINES COMPANY (US) | 2015-02-03 | — | — | US | disclosed |
| EP-2790662-A1 | METHODS AND COMPOSITIONS TO IMPART MEMORY EFFECTS ONTO BIOSURFACES | Avon Products, Inc. (US) | 2014-10-22 | — | — | EP | disclosed |
| US-20130230571-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2013-09-05 | — | — | US | disclosed |
| EP-2624834-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | Elixir Medical Corporation (US) | 2013-08-14 | — | — | EP | disclosed |
| WO-2013090316-A1 | METHODS AND COMPOSITIONS TO IMPART MEMORY EFFECTS ONTO BIOSURFACES | AVON PRODUCTS, INC. (US) | 2013-06-20 | — | — | WO | disclosed |
| US-20130146080-A1 | Methods and Compositions to Impart Memory Effects onto Biosurfaces | AVON PRODUCTS, INC. (US) | 2013-06-13 | — | — | US | disclosed |
| WO-2012047813-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2012-04-12 | — | — | WO | disclosed |
| CN-102231969-A | Macrocyclic lactone compounds and methods for their use | ELIXIR MEDICAL CORP | 2011-11-02 | — | — | CN | disclosed |
| EP-2352459-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | Elixir Medical Corporation (US) | 2011-08-10 | — | — | EP | disclosed |
| US-20100113333-A1 | PHOSPHONATED GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS AND USES THEREOF FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS | TARGANTA THERAPEUTICS, INC. (CA) | 2010-05-06 | — | — | US | disclosed |
| WO-2010040064-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2010-04-08 | — | — | WO | disclosed |
| US-20100086579-A1 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE | ELIXIR MEDICAL CORPORATION (US) | 2010-04-08 | — | — | US | disclosed |
| US-20080287396-A1 | Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections | TARGANTA THERAPEUTICA INC. (CA) | 2008-11-20 | — | — | US | disclosed |